Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer
about
RhoA as a mediator of clinically relevant androgen action in prostate cancer cellsAndrogen Receptor Structure, Function and Biology: From Bench to BedsideRho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and diseaseInhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer.Minireview: Tipping the balance: ligand-independent activation of steroid receptors.Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.Minireview: Alternative activation pathways for the androgen receptor in prostate cancer.Androgen receptor signaling in prostate cancer development and progression.A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancerVav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survivalNovel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth.Pathway Analysis of Genome-wide Association Study in Childhood Leukemia among Hispanics.Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease.The role of microRNA in castration-resistant prostate cancer.RhoC and guanine nucleotide exchange factor Net1 in androgen-unresponsive mouse mammary carcinoma SC-4 cells and human prostate cancer after short-term endocrine therapy.The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.Inhibition of Vav3 gene can promote apoptosis of human gastric cancer cell line MGC803 by regulating ERK pathway.RhoGDIα downregulates androgen receptor signaling in prostate cancer cells.Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia.Targeting geranylgeranylation reduces adrenal gland tumor burden in a murine model of prostate cancer metastasisShort androgen receptor poly-glutamine-promoted endometrial cancer is associated with benzo[a]pyrene-mediated aryl hydrocarbon receptor activation.Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenograftsTargeting protein geranylgeranylation slows tumor development in a murine model of prostate cancer metastasis.Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities.Androgen deprivation and immunotherapy for the treatment of prostate cancer
P2860
Q24618899-D4E6D366-A00A-4354-BDAD-95D8BEC16FEFQ26750866-11DF3C13-1232-4B03-9279-0284CED891E2Q26853181-B5ABA687-C2A2-4B4B-B067-E5C977B20D96Q30419413-59C5C2DA-9106-4669-9D7D-01A039009C38Q33631775-502E0AE8-8D18-4DF9-9E08-D300C5FCC158Q33658285-39C8E520-2F7C-46CF-A13E-53E2DC224E0DQ34540405-2E1AF89F-EE5B-40C0-9B52-0EDD03B78FA4Q35001285-B8CEA946-B4D1-4A5B-AE41-2A6F8A078277Q35183663-A340A07B-2B88-4E13-947F-83E2EC1A6721Q35465076-2582C493-4AB8-4573-817A-E98296745D6DQ36454548-13FA441F-1CD0-4B0D-B510-B3B2D68BD4AEQ36635865-F3AC1CA5-050F-4BE1-ACD7-5F2F67A33CB8Q36918215-E4E40FF6-F123-4D24-8368-24FB6B3500E9Q37399268-984BAB9E-2BDA-4BAF-98E7-D39E438DB763Q38072297-A57C8F6F-C91A-4C15-8916-815605580FA6Q38220789-1F2EE8C9-830F-41B3-B12A-88C0F8B62B74Q38330186-0C31E288-A9D4-4AA7-822E-8FB6AE9DDF42Q38792226-456F2A01-B008-493A-ADDF-718E23EDE940Q38809679-EDE36791-FC80-41BA-B945-4393924A6343Q39114221-ED99FA8A-BF29-41D7-A198-D7E9DCBBECCEQ39169561-471EDC18-3149-442D-9E60-30DCAA9187FEQ39830389-1D8B3263-5B6F-4442-B7D1-1B1789EB710DQ40092714-61281FA5-B91E-4EC1-A73B-1965020B432DQ42671762-2E95F769-0906-4E56-B8F7-8A2C63DF1BCAQ47138834-71DD47AB-CCD8-4602-A93B-C554B6433F25Q52683959-094A1D09-4DD4-430E-9B28-4B961C12AD46Q57115565-921AA77F-1CBB-4526-A643-F5D1FFFFED1F
P2860
Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Ligand-independent activation ...... e signaling in prostate cancer
@ast
Ligand-independent activation ...... e signaling in prostate cancer
@en
type
label
Ligand-independent activation ...... e signaling in prostate cancer
@ast
Ligand-independent activation ...... e signaling in prostate cancer
@en
prefLabel
Ligand-independent activation ...... e signaling in prostate cancer
@ast
Ligand-independent activation ...... e signaling in prostate cancer
@en
P2093
P2860
P356
P1476
Ligand-independent activation ...... e signaling in prostate cancer
@en
P2093
Carol A Maiorino
Joanne Faysal
Kerry L Burnstein
Leah S Lyons
Shuyun Rao
Wayne Balkan
P2860
P304
P356
10.1210/ME.2007-0158
P577
2007-12-13T00:00:00Z